Xavier R.
- Country
- France
- Department
- Gastroenterology
Research Overview
- A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of 3 Active Dose Regimens of MORF-057 in Adults with Moderately to Severely Active Ulcerative Colitis (EMERALD-2)
- Phase II Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Patients with Moderate to Severe Ulcerative Colitis
- One-Year Real-World Effectiveness of Subcutaneous Guselkumab in Adults with Crohn’s Disease
Data & Insights
Has run more than one trial at 491 of 721 partner sites.
Specializations
Inflammatory Bowel Disease Management
This investigator specializes in treating patients with inflammatory bowel disease (IBD), focusing on both ulcerative colitis and Crohn's disease. Their research encompasses various therapeutic approaches for managing moderate to severe cases of these conditions.
- Advanced therapeutic interventions
- Long-term disease management strategies
- Novel treatment combinations
Their work includes evaluating innovative therapeutic agents and investigating different treatment regimens for optimal patient outcomes.
Therapeutic Evaluation
The investigator conducts extensive research in clinical response assessment and endoscopic improvement in IBD patients. Their work involves evaluating various therapeutic agents for both induction and maintenance therapy.
- Treatment efficacy assessment
- Disease activity monitoring
- Patient response evaluation
They focus on determining therapeutic effectiveness through comprehensive clinical and endoscopic assessments.
Treatment Innovation
The investigator explores targeted therapies and combination treatments for IBD management. Their research includes investigating new therapeutic approaches and treatment strategies for patients with inadequate response to conventional therapies.
- Novel therapeutic agents
- Treatment optimization methods
- Long-term safety evaluation
Their work contributes to advancing treatment options for patients with moderate to severe inflammatory bowel conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.